{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T10:07:51Z","timestamp":1770631671070,"version":"3.49.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2005,2,12]],"date-time":"2005-02-12T00:00:00Z","timestamp":1108166400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1007\/s00228-004-0887-0","type":"journal-article","created":{"date-parts":[[2005,2,11]],"date-time":"2005-02-11T11:00:17Z","timestamp":1108119617000},"page":"103-111","source":"Crossref","is-referenced-by-count":11,"title":["Access of HTB, main metabolite of triflusal, to cerebrospinal fluid in healthy volunteers"],"prefix":"10.1007","volume":"61","author":[{"given":"M.","family":"Valle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Barbanoj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Donner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Izquierdo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Herranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. G.","family":"Eichler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,2,12]]},"reference":[{"issue":"2","key":"CR1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","volume":"21","author":"PL McGeer","year":"1995","unstructured":"McGeer PL, McGeer EG (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Rev 21(2):195\u2013218","journal-title":"Brain Res Rev"},{"issue":"2","key":"CR2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.47.2.425","volume":"47","author":"PL McGeer","year":"1996","unstructured":"McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer\u2019s disease: a review of 17 epidemiologic studies. Neurology 47(2):425\u2013432","journal-title":"Neurology"},{"issue":"5","key":"CR3","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0197-4580(95)00092-S","volume":"16","author":"IR Mackenzie","year":"1995","unstructured":"Mackenzie IR, Hao C, Munoz DG (1995) Role of microglia in senile plaque formation. Neurobiol Aging 16(5):797\u2013804","journal-title":"Neurobiol Aging"},{"issue":"6","key":"CR4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2165\/00003495-199855060-00011","volume":"55","author":"W McNeely","year":"1998","unstructured":"McNeely W, Goa KL (1998) Triflusal. Drugs 55(6):823\u2013833","journal-title":"Drugs"},{"issue":"2","key":"CR5","first-page":"343","volume":"237","author":"J Garc\u00eda Rafanell","year":"1979","unstructured":"Garc\u00eda Rafanell J, Planas JM, Puig Parellada P (1979) Comparison of the inhibitory effects of acetylsalicylic and triflusal on enzymes related to thrombosis. Arch Int Pharmacodyn Ther 237(2):343\u2013350","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"CR6","first-page":"510","volume":"22","author":"M Rutllant Borrel","year":"1977","unstructured":"Rutllant Borrel M, Felez J, Diaz JM, Vicente JM, Garc\u00eda Rafanell J (1977) Effect of triflusal (UR-1501) a potential antithrombotic agent, on blood coagulation and platelet antiaggregation in man. Curr Ther Res 22:510\u2013521","journal-title":"Curr Ther Res"},{"key":"CR7","first-page":"357","volume":"7","author":"MJ Dom\u00ednguez","year":"1985","unstructured":"Dom\u00ednguez MJ, Vacas H, Saez Y, Olabarria I, Velasco A, Iriarte JA, Forn J (1985) Effects on triflusal with prosthetic heart valves. Clin Ther 7:357\u2013360","journal-title":"Clin Ther"},{"issue":"4","key":"CR8","first-page":"273","volume":"10","author":"JP DeLa Cruz","year":"1988","unstructured":"De La Cruz JP, Pav\u00eda J, Bellido I, Gonz\u00e1lez MC, S\u00e1nchez de la Cuesta F (1988) Platelet antiaggregator effect of triflusal human whole blood. Methods Find Exp Clin Pharmacol 10(4):273\u2013277","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0733-8619(18)30233-0","volume":"10","author":"A Bucham","year":"1992","unstructured":"Bucham A (1992) Advances in cerebral ischemia: experimental approaches. Neurol Clin 10:49\u201361","journal-title":"Neurol Clin"},{"key":"CR10","first-page":"753","volume":"4","author":"A Fern\u00e1ndezde Arriba","year":"1999","unstructured":"Fern\u00e1ndez de Arriba A, Cavalcanti F, Miralles A, Bay\u00f3n Y, Alonso M, Merlos M, Garc\u00eda-Rafanell J, Forn J (1999) Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal and its deacetylated metabolite 2-hydroxy-4-trifluoromethylbenzoic acid. Mol Pharmacol 4:753\u2013761","journal-title":"Mol Pharmacol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1038\/sj.bjp.0702441","volume":"126","author":"A Bay\u00f3n","year":"1999","unstructured":"Bay\u00f3n A, Alonso A, S\u00e1nchez Crespo M (1999) 4-trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor B activation. Br J Pharmacol 126:1359\u20131366","journal-title":"Br J Pharmacol"},{"issue":"4","key":"CR12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF03189971","volume":"16","author":"J Ramis","year":"1991","unstructured":"Ramis J, Mis R, Forn J, Torrent J, Gorina E, Jane F (1991) Pharmacokinetics of triflusal and its main metabolite HTB in healthy subjects following a single oral dose. Eur J Drug Metab Pharmacokinet 16(4):269\u2013273","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1007\/BF01371006","volume":"19","author":"TH Grasela","year":"1991","unstructured":"Grasela TH, Sheiner LB (1991) Pharmacostatistical modeling for observational data. J Pharmacokinet Biopharm 19:25S\u201336S","journal-title":"J Pharmacokinet Biopharm"},{"key":"CR14","unstructured":"Beal SL, Sheiner LB (1998) NONMEM users\u2019 guides. NONMEM project group. University of California at San Francisco, San Francisco"},{"key":"CR15","volume-title":"Non linear models for repeated measurement data","author":"M Davidian","year":"1995","unstructured":"Davidian M, Giltinan DM (1995) Non linear models for repeated measurement data. CRC Press, Boca Raton"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/cpt1979253358","volume":"25","author":"LB Sheiner","year":"1979","unstructured":"Sheiner LB, Stanski DR, Vozeh S, Miller R, Ham J (1979) Simultaneous modelling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. Clin Pharmacol Ther 25:358\u2013371","journal-title":"Clin Pharmacol Ther"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0169-2607(98)00067-4","volume":"58","author":"EN Jonsson","year":"1999","unstructured":"Jonsson EN, Karlsson MO (1999) Xpose: an S-PLUS based population pharmacokinetic\/pharmacodynamic model building aid for NONMEM. Comput Methods Programs Biomed 58:51\u201364","journal-title":"Comput Methods Programs Biomed"},{"issue":"10","key":"CR18","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/00003088-200241100-00001","volume":"41","author":"EC Lange de","year":"2002","unstructured":"de Lange EC, Danhof M (2002) Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain. Clin Pharmacokinet 41(10):691\u2013703","journal-title":"Clin Pharmacokinet"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1161\/hs1001.097243","volume":"32","author":"L Acarin","year":"2001","unstructured":"Acarin L, Gonz\u00e1lez B, Castellano B (2001) Triflusal post-treatment inhibits glial nuclear Factor-kB, downregulates the glial response, and is neuroprotective in an exocitotoxic injury model in postnatal brain. Stroke 32:2394\u20132402","journal-title":"Stroke"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1161\/01.STR.0000028184.80776.58","volume":"23","author":"L Acarin","year":"2002","unstructured":"Acarin L, Gonz\u00e1lez B, Castellano B (2002) Decrease of proinflammatory molecules correlates with neuroprotective effect of the fluorinated salicylate triflusal after postnatal exocitotoxic damage. Stroke 23:2499\u20132505","journal-title":"Stroke"},{"issue":"3","key":"CR21","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00688317","volume":"37","author":"SD Baker","year":"1996","unstructured":"Baker SD, Heideman RL, Crom WR, Kuttesch JF, Gajja A, Stewart CF (1996) Cerebrospinal fluid pharmacokinetics and penetration of continuous infusion topotecan in children with central nervous system tumors. Cancer Chemother Pharm 37(3):195\u2013202","journal-title":"Cancer Chemother Pharm"},{"issue":"4","key":"CR22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1023\/A:1011010528642","volume":"18","author":"S Sato","year":"2001","unstructured":"Sato S, Kitawa S, Nakajima M, Shimada K, Honda A, Miyazaki H (2001) Assessment of tear concentrations on therapeutic drug monitoring. II. Pharmacokinetic analysis of valproic acid in guinea pig serum, cerebrospinal fluid, and tears. Pharm Res 18(4):500\u2013509","journal-title":"Pharm Res"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2125.1998.00780.x","volume":"46","author":"BJ Anderson","year":"1998","unstructured":"Anderson BJ, Holford NHG, Wollard GA, Chan PLS (1998) Paracetamol plasma and cerebrospinal fluid pharmacokinetics in children. Br J Clin Pharmacol 46:237\u2013243","journal-title":"Br J Clin Pharmacol"},{"key":"CR24","first-page":"114","volume-title":"Clinical pharmacokinetics: concepts and applications","author":"M Rowland","year":"1995","unstructured":"Rowland M, Tozer TN (1995a) Clinical pharmacokinetics: concepts and applications. Williams & Wilkins, Baltimore, pp 114\u2013116"},{"key":"CR25","first-page":"140","volume-title":"Clinical pharmacokinetics: concepts and applications","author":"M Rowland","year":"1995","unstructured":"Rowland M, Tozer TN (1995b) Clinical pharmacokinetics: concepts and applications. Williams & Wilkins, Baltimore, pp 140\u2013142"},{"key":"CR26","first-page":"912","volume":"288","author":"H Tanaka","year":"1999","unstructured":"Tanaka H, Mizojiri K (1999) Drug-protein binding and blood-brain barrier permeability. J Pharmacol Exp Ther 288:912\u2013918","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"CR27","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1053\/euhj.1999.1874","volume":"21","author":"JM Cruz-Fern\u00e1ndez","year":"2000","unstructured":"Cruz-Fern\u00e1ndez JM, L\u00f3pez-Bescos L, Garc\u00eda-Dorado D, L\u00f3pez-Garc\u00eda Aranda V, Cabades A, Mart\u00edn-Jadraque L, Velasco JA, Castro-Beiras A, Torres F, Marfil F, Navarro E (2000) Randomized comparative trial of triflusal and aspirin following acute myocardial infarction. Eur Heart J 21(6):457\u2013465","journal-title":"Eur Heart J"},{"issue":"4","key":"CR28","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1161\/01.STR.0000063141.24491.50","volume":"34","author":"J Matias-Guiu","year":"2003","unstructured":"Matias-Guiu J, Ferro JM, Alvarez-Sab\u00edn J, Torres F, Jim\u00e9nez MD, Lago A, Melo T, TACIP Investigators (2003) Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction. Stroke 34(4):840\u2013848","journal-title":"Stroke"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1212\/01.WNL.0000113757.34662.AA","volume":"62","author":"A Culebras","year":"2004","unstructured":"Culebras A, Rotta-Escalante R, Vila J, Dom\u00ednguez R, Abiuisi G, Famulari A, Rey R, Bauso-Toselli L, Gori H, Ferrari J, Reich E, TAPIRSS investigators (2004) Triflusal vs aspirin for prevention of cerebral infarction. A randomized stroke study. Neurology 62:1073\u20131080","journal-title":"Neurology"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-004-0887-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-004-0887-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-004-0887-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T08:41:35Z","timestamp":1558687295000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-004-0887-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2,12]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1007\/s00228-004-0887-0","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,2,12]]}}}